TrialCancer immunology, immunotherapy : CII2020

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.

Steve Boudewijns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.